How the 2026/27 Australian Federal Budget Will Benefit the Emerging Biotech Industry
The Federal Budget announced last night has introduced several major reforms to the Australian R&D Tax Incentive (RDTI) program, creating […]
General News
Meet us at Bio Korea 2026
PharmSky Research is heading to BIO-Korea! đź“ŤCoex, Seoulđź—“27 – 30 April Our Director of Business Development, Murali Nair, will be
PharmSky Research at Australia–France Clinical Trials Seminar
PharmSky Research to Participate in Australia–France Clinical Trials Seminar PharmSky Research will participate in the Australia–France Clinical Trials Seminar, taking
PharmSky Research to Attend BIO-Europe Spring 2026
PharmSky Research will attend BIO-Europe Spring 2026, taking place from 23–25 March 2026 in Lisbon, Portugal. As part of our
PharmSky Research at Clinical Trials Festival Asia
PharmSky Research will participate in Clinical Trials Festival Asia 2026, taking place from 10–12 March in Singapore. Murali Nair, Director
PharmSky Research at BIO-Europe 2025
PharmSky Research will participate in BIO-Europe 2025, taking place from November 3–5, 2025, at the Vienna Congress and Convention Center,
PharmSky Research at CPHI Frankfurt 2025
PharmSky Research will be attending CPHI Frankfurt 2025, taking place from 28–30 October at Messe Frankfurt, Germany. Our team will
PharmSky Research at AusBiotech 2025
October 21–24 | Melbourne Convention and Exhibition Centre
PharmSky Awarded TGA GMP Manufacturing License — A Major Milestone in Our Growth as a Clinical Trial Partner
It’s Official – Good Manufacturing Practice (GMP) licensed We are incredibly proud to share that PharmSky has officially been granted
